Illinois Municipal Retirement Fund Has $936,000 Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Illinois Municipal Retirement Fund reduced its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 70.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 26,299 shares of the medical instruments supplier's stock after selling 63,507 shares during the period. Illinois Municipal Retirement Fund's holdings in DENTSPLY SIRONA were worth $936,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Beach Investment Counsel Inc. PA lifted its stake in shares of DENTSPLY SIRONA by 1.4% in the 4th quarter. Beach Investment Counsel Inc. PA now owns 22,125 shares of the medical instruments supplier's stock worth $787,000 after acquiring an additional 306 shares during the period. Tokio Marine Asset Management Co. Ltd. lifted its stake in shares of DENTSPLY SIRONA by 5.4% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 6,950 shares of the medical instruments supplier's stock worth $237,000 after acquiring an additional 359 shares during the period. VisionPoint Advisory Group LLC lifted its stake in shares of DENTSPLY SIRONA by 104.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier's stock worth $26,000 after acquiring an additional 395 shares during the period. Teacher Retirement System of Texas lifted its stake in shares of DENTSPLY SIRONA by 2.5% in the 3rd quarter. Teacher Retirement System of Texas now owns 16,471 shares of the medical instruments supplier's stock worth $563,000 after acquiring an additional 397 shares during the period. Finally, Exchange Traded Concepts LLC lifted its stake in shares of DENTSPLY SIRONA by 41.2% in the 3rd quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier's stock worth $51,000 after acquiring an additional 439 shares during the period. 95.70% of the stock is owned by hedge funds and other institutional investors.


Wall Street Analyst Weigh In

Several research firms have recently commented on XRAY. Leerink Partnrs restated an "outperform" rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. StockNews.com upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Friday, January 19th. Needham & Company LLC reiterated a "buy" rating and issued a $42.00 price objective on shares of DENTSPLY SIRONA in a research note on Thursday, February 29th. SVB Leerink initiated coverage on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. They issued an "outperform" rating and a $42.00 price objective for the company. Finally, Piper Sandler raised their price objective on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a "neutral" rating in a research note on Friday, January 12th. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of "Moderate Buy" and a consensus price target of $39.50.

Check Out Our Latest Research Report on DENTSPLY SIRONA

DENTSPLY SIRONA Price Performance

XRAY traded up $0.12 during midday trading on Monday, reaching $30.69. 2,029,953 shares of the company's stock were exchanged, compared to its average volume of 3,308,996. The stock has a market capitalization of $6.36 billion, a PE ratio of -49.31, a P/E/G ratio of 1.24 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 1-year low of $26.27 and a 1-year high of $43.24. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95. The business's 50-day moving average price is $32.53 and its 200 day moving average price is $32.78.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 EPS for the quarter, topping analysts' consensus estimates of $0.43 by $0.01. The business had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $972.61 million. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The company's quarterly revenue was up 3.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.46 earnings per share. As a group, equities analysts anticipate that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 2.09%. This is an increase from DENTSPLY SIRONA's previous quarterly dividend of $0.14. The ex-dividend date of this dividend was Wednesday, March 27th. DENTSPLY SIRONA's payout ratio is presently -103.22%.

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Read More

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Should you invest $1,000 in DENTSPLY SIRONA right now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Featured Articles and Offers

AMD is Down 35%. Now is the Time to Buy the Dip

AMD is Down 35%. Now is the Time to Buy the Dip

AMD stock is at a critical turning point. The market is down 7% following the release but showing some signs of support at a key level. That level aligns with the prior lows and maybe the bottom for t

Search Headlines: